Anti-TYK2 (phospho Y1054 + Y1055) antibody [EPR28591-25]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal TYK2 phospho Y1054 + Y1055 antibody. Suitable for WB, IP, Dot and reacts with Human, Synthetic peptide samples.
View Alternative Names
Non-receptor tyrosine-protein kinase TYK2, TYK2
- IP
Supplier Data
Immunoprecipitation - Anti-TYK2 (phospho Y1054 + Y1055) antibody [EPR28591-25] (AB314878)
TYK2 (phospho Y1054 + Y1055) was immunoprecipitated from 0.35 mg U266B1 (human multiple myeloma B lymphocyte) starved for 16 hours, then treated with 50ng/ml IFN alpha for 15 minutes whole cell lysate with ab314878 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab314878 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : U266B1 (human multiple myeloma B lymphocyte) starved for 16 hours, then treated with 50ng/ml IFN alpha for 15 minutes whole cell lysate Lane 2 : ab314878 IP in U266B1(human multiple myeloma B lymphocyte) starved for 16 hours, then treated with 50ng/ml IFN alpha for 15 minutes whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab314878 in U266B1 starved for 16 hours, then treated with 50ng/ml IFN alpha for 15 minutes whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-TYK2 (phospho Y1054 + Y1055) antibody [EPR28591-25] (ab314878) at 1/30 dilution
All lanes:
U266B1 (human multiple myeloma B lymphocyte) starved for 16 hours, then treated with 50ng/ml IFN alpha for 15 minutes whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-TYK2 (phospho Y1054 + Y1055) antibody [EPR28591-25] (AB314878)
Blocking and diluting buffer and concentration : 5% NFDM/TBST In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution. In Western blot, Anti-TYK2 antibody - Total protein control (ab303500) staining at 1/1000 dilution
All lanes:
Western blot - Anti-TYK2 (phospho Y1054 + Y1055) antibody [EPR28591-25] (ab314878) at 1/1000 dilution
Lane 1:
Untreated U266B1 (human multiple myeloma B lymphocyte) starved for 16 hours whole cell lysate (untreated membrane) at 20 µg
Lane 2:
U266B1 starved for 16 hours, then treated with 50ng/ml IFN alpha and 10μM MG-132 for 15 minutes whole cell lysate (untreated membrane) at 20 µg
Lane 3:
U266B1 starved for 16 hours, then treated with 50ng/ml IFN alpha and 10μM MG-132 for 15 minutes whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 135 kDa,37 kDa,140 kDa
false
Exposure time: 180s
- Dot
Supplier Data
Dot Blot - Anti-TYK2 (phospho Y1054 + Y1055) antibody [EPR28591-25] (AB314878)
Dot blot analysis of TYK2 (phospho Y1054 + Y1055) using ab314878 at 1 : 1000 (0.517 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution. Lane 1 : TYK2 (phospho Tyr1054+Tyr1055) peptide a Lane 2 : TYK2 (phospho Tyr1054+Tyr1055) peptide b Lane 3 : TYK2 (phospho Tyr1054) peptide c Lane 4 : TYK2 (phospho Tyr1055) peptide d Lane 5 : TYK2 non-phospho peptide e Exposure time : 180 seconds Blocking and diluting buffer and concentration : 5% NFDM/TBST
Related conjugates and formulations (1)
-
Anti-TYK2 (phospho Y1054 + Y1055) antibody [EPR28591-25] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TYK2 mediates intracellular signaling that affects both innate and adaptive immune responses. It associates with cytokine receptors forming functional complexes that are critical for initiating JAK-STAT signaling. This type of signaling is responsible for regulating gene expression after cytokine binding. TYK2 is known for interacting with Type I interferons and interleukin-10 family cytokines indicating its importance in immune regulation.
Pathways
TYK2 acts within the JAK-STAT pathway a fundamental signaling cascade triggered by various cytokines and growth factors. The JAK-STAT pathway includes key partners such as STAT1 STAT2 and STAT3 proteins which are phosphorylated by TYK2 to propagate signal transduction. Additionally TYK2 is involved in the 'intercept blocking buffer' mechanism that adjusts signal strength thereby ensuring appropriate cellular responses to external stimuli.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com